Clinical Trial Update: A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients [Phase 1, Phase 2]

View source ↗

Summary

A prospective pilot study evaluating the efficacy and safety of baricitinib in active primary Sjogren's syndrome across Phase 1 and Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren's Syndrome | Phase 1, Phase 2 | Status: COMPLETED